| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |